Co-Authors
This is a "connection" page, showing publications co-authored by Zachary Herrmann and Sarah Slabaugh.
Connection Strength
0.674
-
Earleywine M, Herrmann Z, Slabaugh S. Suicide after psychedelic-assisted treatment in context. Psychiatry Res. 2025 Apr; 346:116399.
Score: 0.245
-
Herrmann Z, Levin AW, Cole SP, Slabaugh S, Barnett B, Penn A, Jain R, Raison C, Rajanna B, Jain S. Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States. Psychedelic Med (New Rochelle). 2023 Sep; 1(3):139-149.
Score: 0.222
-
Herrmann Z, Earleywine M, De Leo J, Slabaugh S, Kenny T, Rush AJ. Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials. J Psychoactive Drugs. 2023 Sep-Oct; 55(4):501-517.
Score: 0.207